glp-1 produced by Glucagon-like peptide (GLP)-1 and GLP-2 are multi-organ hormones that Frontiers | GLP-1 Receptor Agonists:

Cancer drugs, genetic variation and the glutathione-S-transferase gene family

Through neural pathways as well as via receptor-mediated effects, GLP-1 reduces postprandial hyperglycemia by stimulation of insulin secretion, suppression of glucagon release, inhibition of gastric emptying and small intestinal peristalsis, and induction of satiety which limits meal size [17]

Pharmacological Treatment of Obesity in Older Adults

The "reduced" form (GSH) is the active, antioxidant-ready state, whereas the "oxidized" form (GSSG) has already expended its electron and must be recycled by the body

Myricetin increases circulating adropin level after activation of glucagon-like peptide1 (GLP-1) receptor in type-1 diabetic rats